Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Non-Small-Cell Lung × copanlisib × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 6 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Neoplasm Metastasis 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Hodgkin Disease 3 Endometrial Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Mantle-Cell 2 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Thrombocytosis 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Recurrence 1 Primary Myelofibrosis 1 Pancreatic Neoplasms 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Metastatic Castration-resistant Prostate Cancer 1

Interventions

Carboplatin 328 Pemetrexed 265 Cisplatin 233 Docetaxel 195 Paclitaxel 181 Radiotherapy 177 Erlotinib Hydrochloride 153 pembrolizumab 146 Gemcitabine 146 Bevacizumab 125 Drug Therapy 118 Radiosurgery 112 Nivolumab 110 osimertinib 93 durvalumab 87 Gefitinib 67 atezolizumab 63 Vinorelbine 63 Surgical Procedures, Operative 62 Magnetic Resonance Spectroscopy 52 Immunotherapy 42 anlotinib 41 Taxes 39 Blood Specimen Collection 38 Ipilimumab 37 130-nm albumin-bound paclitaxel 37 Specimen Handling 35 Immune Checkpoint Inhibitors 35 Radiation 33 Albumin-Bound Paclitaxel 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04895579 2025-11-18

LCD

University of Kentucky

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡